UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 321

Sortiert nach

Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction

Expert review of anti-infective therapy, 2020-01, Vol.18 (1), p.5-15

2020

Volltextzugriff (PDF)

Novel classes of antibiotics or more of the same?

British journal of pharmacology, 2011-05, Vol.163 (1), p.184-194

2011

Volltextzugriff (PDF)

Normal high-sensitivity cardiac troponin for ruling-out inpatient mortality in acute COVID-19

PloS one, 2023-04, Vol.18 (4), p.e0284523-e0284523

2023

Volltextzugriff (PDF)

Stress Wars: the Direct Role of Host and Bacterial Molecular Chaperones in Bacterial Infection

Infection and immunity, 2006-07, Vol.74 (7), p.3693-3706

2006

Volltextzugriff (PDF)

Effective prognostic and clinical risk stratification in COVID‐19 using multimodality biomarkers

Journal of internal medicine, 2023-07, Vol.294 (1), p.21-46

2023

Volltextzugriff (PDF)

Mycobacterium tuberculosis Mutant Lacking the groEL Homologue cpn60.1 Is Viable but Fails To Induce an Inflammatory Response in Animal Models of Infection

Infection and Immunity, 2008-04, Vol.76 (4), p.1535-1546

2008

Volltextzugriff (PDF)

A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects in vitro

Journal of antimicrobial chemotherapy, 2016-04, Vol.71 (4), p.964-974

2016

Volltextzugriff (PDF)

Mycobacterium tuberculosis acg gene is required for growth and virulence in vivo

PloS one, 2011-06, Vol.6 (6), p.e20958

2011

Volltextzugriff (PDF)

Acute and persistent Mycobacterium tuberculosis infections depend on the thiol peroxidase TpX

PloS one, 2009-04, Vol.4 (4), p.e5150-e5150

2009

Volltextzugriff (PDF)

Comparison of the Moonlighting Actions of the Two Highly Homologous Chaperonin 60 Proteins of Mycobacterium tuberculosis

Infection and Immunity, 2010-07, Vol.78 (7), p.3196-3206

2010

Volltextzugriff (PDF)

Deletion of the Mycobacterium tuberculosis α-Crystallin-Like hspX Gene Causes Increased Bacterial Growth In Vivo

Infection and Immunity, 2006-02, Vol.74 (2), p.861-868

2006

Volltextzugriff (PDF)

Targeting non-multiplying organisms as a way to develop novel antimicrobials

Trends in pharmacological sciences (Regular ed.), 2008-03, Vol.29 (3), p.143-150

2008

Volltextzugriff (PDF)

Translational Model‐Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development

Clinical pharmacology and therapeutics, 2020-08, Vol.108 (2), p.274-286

2020

Volltextzugriff (PDF)

Antibiotic resistance—the need for global solutions

The Lancet infectious diseases, 2013-12, Vol.13 (12), p.1057-1098

2013

Volltextzugriff (PDF)

Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studies

Journal of antimicrobial chemotherapy, 2013-02, Vol.68 (2), p.374-384

2013

Volltextzugriff (PDF)

Gut microbiota and development of atopic eczema in 3 European birth cohorts

Journal of allergy and clinical immunology, 2007-08, Vol.120 (2), p.343-350

2007

Volltextzugriff (PDF)

Comparing the action of HT61 and chlorhexidine on natural and model Staphylococcus aureus membranes

Journal of antibiotics, 2017-10, Vol.70 (10), p.1020-1025

2017

Volltextzugriff (PDF)

Characterisation of Ferritin–Lymphocyte Ratio in COVID-19

Biomedicines, 2023-10, Vol.11 (10), p.2819

2023

Volltextzugriff (PDF)

Forecasting Clinical Dose–Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin

Clinical pharmacology and therapeutics, 2018-12, Vol.104 (6), p.1208-1218

2018

Volltextzugriff (PDF)

Comparison of Lymphocyte-CRP Ratio to Conventional Inflammatory Markers for Predicting Clinical Outcomes in COVID-19

Journal of personalized medicine, 2023-05, Vol.13 (6), p.909

2023

Volltextzugriff (PDF)

Low CRB-65 Scores Effectively Rule out Adverse Clinical Outcomes in COVID-19 Irrespective of Chest Radiographic Abnormalities

Biomedicines, 2023-08, Vol.11 (9), p.2423

2023

Volltextzugriff (PDF)

Sterilizing Activities of Fluoroquinolones against Rifampin-Tolerant Populations of Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy, 2003-02, Vol.47 (2), p.653-657

2003

Volltextzugriff (PDF)

Modulation of allergic inflammation in the lung by a peptide derived from Mycobacteria tuberculosis chaperonin 60.1

Clinical and experimental allergy, 2020-04, Vol.50 (4), p.508-519

2020

Volltextzugriff (PDF)

Reduced diversity in the early fecal microbiota of infants with atopic eczema

Journal of allergy and clinical immunology, 2008, Vol.121 (1), p.129-134

2008

Volltextzugriff (PDF)

A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis

Journal of pharmacokinetics and pharmacodynamics, 2020-10, Vol.47 (5), p.421-430

2020

Volltextzugriff (PDF)

1 – 25 von 321

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(288)
Mit Volltextzugriff
(270)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(207)
Life Sciences & Biomedicine
(179)
Humans
(110)
Microbiology
(59)
Animals
(54)
Biological And Medical Sciences
(49)
Female
(43)
Male
(36)
Mycobacterium Tuberculosis
(35)
Medical Sciences
(30)
Pharmacology & Pharmacy
(30)
Biochemistry & Molecular Biology
(28)
Immunology
(28)
Infectious Diseases
(28)
Mice
(28)
Fundamental And Applied Biological Sciences. Psychology
(24)
Middle Aged
(22)
Physical Sciences
(20)
Bacteria
(19)
Adult
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction

Novel classes of antibiotics or more of the same?

Normal high-sensitivity cardiac troponin for ruling-out inpatient mortality in acute COVID-19

Stress Wars: the Direct Role of Host and Bacterial Molecular Chaperones in Bacterial Infection

Effective prognostic and clinical risk stratification in COVID‐19 using multimodality biomarkers

Mycobacterium tuberculosis Mutant Lacking the groEL Homologue cpn60.1 Is Viable but Fails To Induce an Inflammatory Response in Animal Models of Infection

A multistate tuberculosis pharmacometric model: a framework for studying anti-tubercular drug effects in vitro

Mycobacterium tuberculosis acg gene is required for growth and virulence in vivo

Acute and persistent Mycobacterium tuberculosis infections depend on the thiol peroxidase TpX

Comparison of the Moonlighting Actions of the Two Highly Homologous Chaperonin 60 Proteins of Mycobacterium tuberculosis

Deletion of the Mycobacterium tuberculosis α-Crystallin-Like hspX Gene Causes Increased Bacterial Growth In Vivo

Targeting non-multiplying organisms as a way to develop novel antimicrobials

Translational Model‐Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development

Antibiotic resistance—the need for global solutions

Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studies

Gut microbiota and development of atopic eczema in 3 European birth cohorts

Comparing the action of HT61 and chlorhexidine on natural and model Staphylococcus aureus membranes

Characterisation of Ferritin–Lymphocyte Ratio in COVID-19

Forecasting Clinical Dose–Response From Preclinical Studies in Tuberculosis Research: Translational Predictions With Rifampicin

Comparison of Lymphocyte-CRP Ratio to Conventional Inflammatory Markers for Predicting Clinical Outcomes in COVID-19

Low CRB-65 Scores Effectively Rule out Adverse Clinical Outcomes in COVID-19 Irrespective of Chest Radiographic Abnormalities

Sterilizing Activities of Fluoroquinolones against Rifampin-Tolerant Populations of Mycobacterium tuberculosis

Modulation of allergic inflammation in the lung by a peptide derived from Mycobacteria tuberculosis chaperonin 60.1

Reduced diversity in the early fecal microbiota of infants with atopic eczema

A model-based analysis identifies differences in phenotypic resistance between in vitro and in vivo: implications for translational medicine within tuberculosis

Suchergebnisse filtern